Lantheus adds TAUKLARIFY to Alzheimer’s imaging toolkit after FDA approval
FDA approves TAUKLARIFY for tau PET imaging in Alzheimer’s evaluation. See how Lantheus’ new tracer fits into the evolving diagnostic market.
Medical Devices & Diagnostics